Tower Research Capital (TRC)’s Envision Healthcare Holdings Inc EVHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-2,259
Closed -$104K 4774
2018
Q3
$104K Buy
2,259
+2,119
+1,514% +$95.2K 0.01% 1322
2018
Q2
$6K Buy
+140
New +$5.75K ﹤0.01% 3042
2017
Q2
Sell
-59
Closed -$4K 3895
2017
Q1
$4K Sell
59
-626
-91% -$42K ﹤0.01% 2407
2016
Q4
$44K Buy
685
+578
+540% +$37.8K ﹤0.01% 1520
2016
Q3
$7K Buy
+107
New +$7.37K ﹤0.01% 2384
2016
Q2
Sell
-221
Closed -$14K 5337
2016
Q1
$14K Sell
221
-48
-18% -$3.15K ﹤0.01% 1665
2015
Q4
$21K Buy
+269
New +$23.2K ﹤0.01% 1266
2015
Q2
Sell
-33
Closed -$4K 5375
2015
Q1
$4K Buy
+33
New +$3.59K ﹤0.01% 3470
2014
Q4
Sell
-1,102
Closed -$114K 5084
2014
Q3
$114K Sell
1,102
-1,085
-50% -$115K 0.01% 821
2014
Q2
$236K Buy
2,187
+1,237
+130% +$127K 0.03% 532
2014
Q1
$96K Buy
+950
New +$95.1K 0.01% 730
2013
Q4
Sell
-1,918
Closed -$149K 5158
2013
Q3
$149K Buy
+1,918
New +$153K 0.02% 971

Other funds holding EVHC

Tower Research Capital (TRC)'s EVHC Position: Q4 2018 in Review

Tower Research Capital (TRC) sold out of Envision Healthcare Holdings Inc (EVHC) in Q4 2018, closing a stake of 2,259 shares — an estimated $104K sold.

Tower Research Capital (TRC) first reported a position in EVHC in Q3 2013 and held it in 12 quarters. The position peaked at $236K in Q2 2014. 4 funds tracked by Wall St. Rank hold EVHC as of Q4 2018.

  • Tower Research Capital (TRC) reported no remaining Envision Healthcare Holdings Inc position as of Q4 2018 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 2,259 Envision Healthcare Holdings Inc shares in Q4 2018, an estimated $104K.
  • Tower Research Capital (TRC) first reported a position in Envision Healthcare Holdings Inc in Q3 2013 and held it in 12 quarters.
  • Tower Research Capital (TRC)'s Envision Healthcare Holdings Inc position peaked at $236K in Q2 2014.
  • 4 funds tracked by Wall St. Rank held Envision Healthcare Holdings Inc as of Q4 2018.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2018, filed 14 Feb 2019.